Owonikoko, Taofeek, Kyriakos Papadopoulos, Melissa Johnson, and et al. “Phase 1 Study of Cemiplimab, a Human Monoclonal Anti-PD-1 Antibody, in Patients With Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-up Efficacy and Safety Data”. SKIN The Journal of Cutaneous Medicine 3, no. 2 (March 11, 2019): 169. Accessed January 10, 2025. https://skin.dermsquared.com/skin/article/view/526.